Teva Pharmaceutical Industries (TEVA) Profit After Tax Growth (5y) (2021 - 2026)
Teva Pharmaceutical Industries (TEVA) Profit After Tax Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.81% |
| Dec 31, 2025 | 24.26% |
| Sep 30, 2025 | 15.99% |
| Jun 30, 2025 | 15.11% |
| Mar 31, 2025 | 25.40% |
| Dec 31, 2024 | -41.47% |
| Sep 30, 2024 | -7.32% |
| Jun 30, 2024 | -4.87% |
| Mar 31, 2024 | -33.99% |
| Dec 31, 2023 | 16.65% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | -37.72% |
| Mar 31, 2023 | -17.33% |
| Dec 31, 2022 | 35.05% |
| Sep 30, 2022 | -36.90% |
| Jun 30, 2022 | 45.85% |
| Mar 31, 2022 | -28.30% |
| Dec 31, 2021 | -15.51% |